Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug

Plus, news about Novartis, Signify Bio, Ocugen, Dynavax and ViGeneron: Cullinan Therapeutics gets rights to T cell engager developed in China: The company made a deal with Chongqing-based Genrix Bio for ...

Related Posts

US urges Supreme Court to decline Oklahoma PBM case

May 29, 2025  0

Trump confirms 'most favored nation' drug price plans

May 12, 2025  0

EMA considers serious eye condition a ‘very rare’ side ...

Jun 6, 2025  0

Comments

Name

Email

Comment

Post Comment